Innospec IOSP Selling General And Administrative Expense And Research And Development Expense

Segments

By segment

See full

Fuel Specialties$26.5M+10.9%

Oilfield Services$25.2M+1.2%

Performance Chemicals$17.7M+14.2%

Other financials

Income statement

See full

Revenue$453.2M+2.8%

Gross profit$123.5M-1.3%

Operating income$36.5M-14.1%

Net income$30.4M-7.3%

EPS (diluted)$1.22-6.9%

Balance sheet

See full

Cash & equivalents$289.1M-3.6%

Total debt$50.6M+14.0%

Total equity$1.3B+6.7%

Total assets$1.8B+2.5%

Cash flow

See full

Operating cash flow$17.6M-37.8%

CapEx$8.9M+6.0%

Free cash flow$8.7M-56.3%

Valuation

See full

Market cap$2.05B-23.6%

Profitability

See full

Gross margin27.4%-1.3pp

Operating margin6.9%-2.6pp

Net margin6.4%—

FCF margin4.5%-1.1pp

Returns & leverage

See full

Return on equity8.8%—

Debt / equity0×0.0×

Current ratio3×+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept iosp:SellingGeneralAndAdministrativeExpenseAndResearchAndDevelopmentExpense.

The official record: Innospec’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's selling general and administrative expense and research and development expense.

Connect your AI assistant and break it down by segment, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innospec's selling general and administrative expense and research and development expense?: Innospec (IOSP) reported selling general and administrative expense and research and development expense of $91.7M in Q1 2026.
How has Innospec's selling general and administrative expense and research and development expense changed year-over-year?: Innospec's selling general and administrative expense and research and development expense increased by 11.8% year-over-year, from $82M to $91.7M.